Tofacitinib N-oxide impurity
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

2028267-73-2Tofacitinib N-oxide impurity

● In Stock

Catalogue No.:VE008142
CAS No.:2028267-73-2
Mol. Formula:C16H20N6O2
Mol. Weight:328.38 g/mol

Additional information on CAS 2028267-73-2

Parent drug

Tofacitinib

IUPAC Name

(3R, ​4R)​-4-​Methyl-​3-​(methyloxido-​7H-​pyrrolo[2, ​3-​d]​pyrimidin-​4-​ylamino)​-​β-​oxo-1-​piperidinepropanenit​rile

Synonyms

N/A

Description

Tofacitinib N oxide impurity (CAS No: 2028267-73-2) Or (3R,4R)-4-Methyl-3-(methyloxido-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-v-oxo-1-piperidinepropanenitrile, Tofacitinib N oxide is an impurity of Tofacitinib, Tofacitinib is a CYP3A4 substrate and a minor CYP2C19 substrate, used in the treatment of rheumatoid arthritis.

Request a Quote

« * » indique les champs nécessaires

Ce champ n’est utilisé qu’à des fins de validation et devrait rester inchangé.
Products quotation
Name
Url